Completed NA INTERVENTIONAL 2-arm NCT01102452

A Study to Evaluate the Blood Glucose Regulation and Safety of PPB-R-203-02 Based Noodle Versus Commercially Available Wet Noodle in Patients With Diabetes

A Randomized, Two-Regimen, Crossover, Comparative Study to Evaluate the Blood Glucose Regulation and Safety of PPB-R-203-02 Based Noodle Versus Commercially Available Wet Noodle in 24 Patients With Diabetes

Sponsor: Pharma Power Biotec Co., Ltd.

Conditions Diabetes Mellitus

Interventions Commercially Available Wet Noodle PPB-R-203-02 Noodle

Updated 6 times since 2017 Last updated: Dec 24, 2012 Started: Apr 30, 2010 Primary completion: Jul 31, 2010 Completion: Jul 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Diabetes Mellitus and is currently completed. Pharma Power Biotec Co., Ltd. leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Apr 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pharma Power Biotec Co., Ltd.

Data source: Pharma Power Biotec Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pingtung City, Taiwan